The AST- and ALT-lowering effects of curcumin were still significant with MD (95% CI) of −3.72 (−6.25, −1.19) and −5.62 (−10.57, −0.66) units/L, respectively, while the association between curcumin and the resolution of hepatic steatosis was slightly stronger with RR (95% CI) of 3.90 (2.01, 7.60), see Supplementary Appendices X–Z. Here, GPT is linked to fatty liver disease.